The Role of lncRNA PCAT6 in Cancers
Long non-coding RNA (lncRNA) PCAT6 is a member of the Prostate Cancer Associated Transcripts family of molecules. In this review, we focus on the latest studies involving PCAT6 in the diagnosis, treatment, and prognosis of malignant tumors of the digestive, respiratory, urinary, reproductive, motion...
Main Authors: | Siying Wang, Zhenyao Chen, Jingyao Gu, Xin Chen, Zhaoxia Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.701495/full |
Similar Items
-
LncRNA PCAT6 mediates UBFD1 expression via sponging miR-545-3p in breast cancer cells
by: Jun-Dong Wu, et al.
Published: (2024-06-01) -
Expression Analysis of Long Non-coding PCAT-1
by: Shaghayegh Sarrafzadeh, et al.
Published: (2017-07-01) -
Unravelling the impact of aging on the human endothelial lncRNA transcriptome
by: Maria-Kyriaki Drekolia, et al.
Published: (2022-10-01) -
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling
by: Xingkang Jiang, et al.
Published: (2022-03-01) -
<i>PCAT6</i> May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers
by: Feng Jiang, et al.
Published: (2021-12-01)